Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutics targeting truncated adenomatous polyposis coli (APC) proteins

Therapeutics targeting truncated adenomatous polyposis coli (APC) proteins

US Patent 9856233 · Granted Jan 2, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Sequential treatment of cancers using 6-thio-dG, checkpoint inhibitors and radia2024
Treatment of drug resistant proliferative diseases with telomerase mediated telo2024
OX2R compounds2024
OX2R compounds2024
OX2R compounds2022
OX2R compounds2022
Method to measure the shortest telomeres2020
Therapeutics targeting truncated adenomatous polyposis coli (APC) proteins2020
Therapeutics targeting truncated adenomatous polyposis coli (APC) proteins2020
Telomerase mediated telomere altering compounds2019
Anti-depression compounds2019
Pro-neurogenic compounds2019